Literature DB >> 18178829

Transcription factor FOXO3a mediates apoptosis in HIV-1-infected macrophages.

Min Cui1, Yunlong Huang, Yong Zhao, Jialin Zheng.   

Abstract

Macrophages serve as a major reservoir for HIV-1 because a large number of macrophages in the brain and lung are infected with HIV-1 during late stage disease. Recent evidence suggests that those HIV-1-infected macrophages play a key role in contributing to tissue damage in AIDS pathogenesis. Macrophages undergo apoptosis upon HIV-1 infection; however, the mechanisms of this process are not well-defined. Previously, we demonstrated that HIV-1 infection inhibits Akt-1, a critical protein for cell survival of macrophages. In the present study, we investigated the involvement of transcription factor FOXO3a in the regulation of HIV-1-mediated apoptosis in macrophages. HIV-1 infection significantly decreased phosphorylation of FOXO3a and promoted FOXO3a translocation to the nucleus in human monocyte-derived macrophages (MDM). Overexpression of a constitutively active FOXO3a increased DNA fragmentation with decreased cell viability in MDM, whereas a dominant-negative mutant of FOXO3a or small interfering RNA for FOXO3a to knockdown the function of FOXO3a in HIV-1-infected MDM decreased DNA fragmentation and protected macrophages from death in HIV-1-infected MDM. Overexpression of constitutively active Akt-1 increased FOXO3a phosphorylation, suggesting that FOXO3a phosphorylation in human MDM is dependent on Akt-1. We therefore conclude that FOXO3a plays an important role in HIV-1-induced cell death of human macrophage. Understanding the PI3K/Akt-1/FOXO3a pathway and its associated death mechanism in macrophages during HIV-1 infection would lead to identification of potential therapeutic avenues for the treatment of HIV-1 infection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18178829      PMCID: PMC2276663          DOI: 10.4049/jimmunol.180.2.898

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  54 in total

1.  Redox regulation of forkhead proteins through a p66shc-dependent signaling pathway.

Authors:  Shino Nemoto; Toren Finkel
Journal:  Science       Date:  2002-03-07       Impact factor: 47.728

Review 2.  Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel.

Authors:  C C Carpenter; D A Cooper; M A Fischl; J M Gatell; B G Gazzard; S M Hammer; M S Hirsch; D M Jacobsen; D A Katzenstein; J S Montaner; D D Richman; M S Saag; M Schechter; R T Schooley; M A Thompson; S Vella; P G Yeni; P A Volberding
Journal:  JAMA       Date:  2000-01-19       Impact factor: 56.272

3.  Macrophage tropism of human immunodeficiency virus type 1 isolates from brain and lymphoid tissues predicts neurotropism independent of coreceptor specificity.

Authors:  P R Gorry; G Bristol; J A Zack; K Ritola; R Swanstrom; C J Birch; J E Bell; N Bannert; K Crawford; H Wang; D Schols; E De Clercq; K Kunstman; S M Wolinsky; D Gabuzda
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

4.  Selective clearance of macrophages in atherosclerotic plaques by autophagy.

Authors:  Stefan Verheye; Wim Martinet; Mark M Kockx; Michiel W M Knaapen; Koen Salu; Jean-Pierre Timmermans; Jeffrey T Ellis; Deborah L Kilpatrick; Guido R Y De Meyer
Journal:  J Am Coll Cardiol       Date:  2007-01-26       Impact factor: 24.094

5.  DNA repair pathway stimulated by the forkhead transcription factor FOXO3a through the Gadd45 protein.

Authors:  Hien Tran; Anne Brunet; Jill M Grenier; Sandeep R Datta; Albert J Fornace; Peter S DiStefano; Lillian W Chiang; Michael E Greenberg
Journal:  Science       Date:  2002-04-19       Impact factor: 47.728

6.  Induction of cell death in human immunodeficiency virus-infected macrophages and resting memory CD4 T cells by TRAIL/Apo2l.

Authors:  J J Lum; A A Pilon; J Sanchez-Dardon; B N Phenix; J E Kim; J Mihowich; K Jamison; N Hawley-Foss; D H Lynch; A D Badley
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

7.  Ebola virus infection of human PBMCs causes massive death of macrophages, CD4 and CD8 T cell sub-populations in vitro.

Authors:  Manisha Gupta; Christina Spiropoulou; Pierre E Rollin
Journal:  Virology       Date:  2007-03-27       Impact factor: 3.616

Review 8.  Human immunodeficiency virus-associated dementia.

Authors:  J C McArthur; N Sacktor; O Selnes
Journal:  Semin Neurol       Date:  1999       Impact factor: 3.420

9.  Monocyte/macrophage suppression in CD11b diphtheria toxin receptor transgenic mice differentially affects atherogenesis and established plaques.

Authors:  Victoria Stoneman; Denise Braganza; Nichola Figg; John Mercer; Richard Lang; Martin Goddard; Martin Bennett
Journal:  Circ Res       Date:  2007-02-22       Impact factor: 17.367

10.  Convergence of TCR and cytokine signaling leads to FOXO3a phosphorylation and drives the survival of CD4+ central memory T cells.

Authors:  Catherine Riou; Bader Yassine-Diab; Julien Van grevenynghe; Roland Somogyi; Larry D Greller; Dominic Gagnon; Sylvain Gimmig; Peter Wilkinson; Yu Shi; Mark J Cameron; Roberto Campos-Gonzalez; Robert S Balderas; David Kelvin; Rafick-Pierre Sekaly; Elias K Haddad
Journal:  J Exp Med       Date:  2006-12-26       Impact factor: 14.307

View more
  24 in total

Review 1.  New insights for FOXO and cell-fate decision in HIV infection and HIV associated neurocognitive disorder.

Authors:  Min Cui; Yunlong Huang; Yong Zhao; Jialin Zheng
Journal:  Adv Exp Med Biol       Date:  2009       Impact factor: 2.622

2.  HIV-induced kidney cell injury: role of ROS-induced downregulated vitamin D receptor.

Authors:  Divya Salhan; Mohammad Husain; Ashaan Subrati; Rohan Goyal; Tejinder Singh; Partab Rai; Ashwani Malhotra; Pravin C Singhal
Journal:  Am J Physiol Renal Physiol       Date:  2012-05-30

3.  Tumor suppressor FOXO3 participates in the regulation of intestinal inflammation.

Authors:  Lobke Snoeks; Christopher R Weber; Kaarin Wasland; Jerrold R Turner; Charles Vainder; Wentao Qi; Suzana D Savkovic
Journal:  Lab Invest       Date:  2009-07-27       Impact factor: 5.662

4.  Small molecule ONC201 inhibits HIV-1 replication in macrophages via FOXO3a and TRAIL.

Authors:  Runze Zhao; Yuju Li; Santhi Gorantla; Larisa Y Poluektova; Hai Lin; Fengtong Gao; Hongyun Wang; Jeffrey Zhao; Jialin C Zheng; Yunlong Huang
Journal:  Antiviral Res       Date:  2019-05-31       Impact factor: 5.970

5.  Toll-like receptor 9-mediated inhibition of apoptosis occurs through suppression of FoxO3a activity and induction of FLIP expression.

Authors:  Eun-Jung Lim; Dae-Weon Park; Jin-Gu Lee; Chu-Hee Lee; Yoe-Sik Bae; Young-Chul Hwang; Jae-Weon Jeong; Byung-Rho Chin; Suk-Hwan Baek
Journal:  Exp Mol Med       Date:  2010-10-31       Impact factor: 8.718

6.  Tat-induced FOXO3a is a key mediator of apoptosis in HIV-1-infected human CD4+ T lymphocytes.

Authors:  Alicja Dabrowska; Nayoung Kim; Anna Aldovini
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

7.  Association of Tat with promoters of PTEN and PP2A subunits is key to transcriptional activation of apoptotic pathways in HIV-infected CD4+ T cells.

Authors:  Nayoung Kim; Sami Kukkonen; Sumeet Gupta; Anna Aldovini
Journal:  PLoS Pathog       Date:  2010-09-16       Impact factor: 6.823

Review 8.  Foxo3a: an integrator of immune dysfunction during HIV infection.

Authors:  Julien van Grevenynghe; Rafael A Cubas; Sandrina DaFonseca; Talibah Metcalf; Cecile L Tremblay; Lydie Trautmann; Rafick-Pierre Sekaly; John Schatzle; Elias K Haddad
Journal:  Cytokine Growth Factor Rev       Date:  2012-06-27       Impact factor: 7.638

9.  Inhibition of p66ShcA longevity gene rescues podocytes from HIV-1-induced oxidative stress and apoptosis.

Authors:  Mohammad Husain; Leonard G Meggs; Himanshu Vashistha; Sonia Simoes; Kevin O Griffiths; Dileep Kumar; Joanna Mikulak; Peter W Mathieson; Moin A Saleem; Luis Del Valle; Sergio Pina-Oviedo; Jin Ying Wang; Surya V Seshan; Ashwani Malhotra; Krzysztof Reiss; Pravin C Singhal
Journal:  J Biol Chem       Date:  2009-04-21       Impact factor: 5.157

10.  Sirt3 blocks the cardiac hypertrophic response by augmenting Foxo3a-dependent antioxidant defense mechanisms in mice.

Authors:  Nagalingam R Sundaresan; Madhu Gupta; Gene Kim; Senthilkumar B Rajamohan; Ayman Isbatan; Mahesh P Gupta
Journal:  J Clin Invest       Date:  2009-08-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.